🇺🇸 FDA
Pipeline program

Decartes-08

RNAC-MG-002 (AURORA)

Phase 3 mab active

Quick answer

Decartes-08 for Myasthaenia Gravis is a Phase 3 program (mab) at Cartesian Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Cartesian Therapeutics
Indication
Myasthaenia Gravis
Phase
Phase 3
Modality
mab
Status
active

Clinical trials